(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 15.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.
Quanterix's revenue in 2025 is $130,203,000.On average, 6 Wall Street analysts forecast QTRX's revenue for 2025 to be $6,344,727,557, with the lowest QTRX revenue forecast at $6,060,725,911, and the highest QTRX revenue forecast at $6,557,728,791. On average, 6 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,138,889,269, with the lowest QTRX revenue forecast at $7,260,259,178, and the highest QTRX revenue forecast at $8,681,201,622.
In 2027, QTRX is forecast to generate $9,264,152,369 in revenue, with the lowest revenue forecast at $8,661,115,980 and the highest revenue forecast at $9,789,648,835.